Oral TheraCLEC™ - Total in Cystic Fibrosis Subjects With Exocrine Pancreatic Insufficiency

Clinical trial NCT00095732 · COMPLETED

Trial details

NCT number: NCT00095732
Sponsor: Anthera Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Cystic Fibrosis Pancreatic Insufficiency

Start date: 2004-06-01
Primary completion: 2005-03-01
Enrollment: 129

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.